Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00080455" target="_blank" >RIV/65269705:_____/24:00080455 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/24:00138888
Result on the web
<a href="https://journals.sagepub.com/doi/10.1177/20406207241285143" target="_blank" >https://journals.sagepub.com/doi/10.1177/20406207241285143</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/20406207241285143" target="_blank" >10.1177/20406207241285143</a>
Alternative languages
Result language
angličtina
Original language name
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions
Original language description
Over recent decades, management of people with hemophilia (PwH) has been greatly improved by scientific advances that have resulted in a rich and varied therapeutic landscape. Nevertheless, treatment limitations continue to drive innovation, and emerging options have the potential to realize further improvement. We advocate four general principles to optimize benefits from innovation: individualizing the treatment approach, targeting 'normal,' making the most of available resources, and considering treatment affordability. Ultimately, all PwH-men and women, of all ages and severities, and worldwide-should have access to treatment that fully prevents bleeding, while allowing personal, social, family, and professional lives of choice. Clearly, we are not there yet, but developing goals/milestones based on the principles we describe may help to achieve this. Graphical abstract
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Therapeutic Advances in Hematology
ISSN
2040-6207
e-ISSN
2040-6215
Volume of the periodical
15
Issue of the periodical within the volume
2024
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
20406207241285143
UT code for WoS article
001327923200001
EID of the result in the Scopus database
2-s2.0-85206105390